Peripheral CGRP release as a marker for neurogenic inflammation: A model system for the study of neuropeptide secretion in rat paw skin

Pain

Volumn 73, Issue 2, 1997, Pages 201-207

  Kilo, Sonja ^a   Harding Rose, Catherine ^a   Hargreaves, Kenneth M ^a   Flores, Christopher M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

CGRP; Neurogenic inflammation; Skin

Indexed keywords

BIOCHEMICAL MARKER; CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HINDLIMB; INFLAMMATION; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SKIN; TISSUE INJURY;

ANIMALS; BASAL METABOLISM; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DISEASE MODELS, ANIMAL; HINDLIMB; MALE; NERVE ENDINGS; NEURITIS; NEUROPEPTIDES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SKIN;

EID: 0030727883     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00108-5     Document Type: Article

References (44)

1. Amann R., Donnerer J., Lembeck F. Ruthenium red selectively inhibits capsaicin-induced release of calcitonin gene-related peptide from the isolated perfused guinea pig lung. Neurosci. Lett. 101(3):1989;311-315.
2. Bayliss W.M. On the origin from the spinal cord of the vaso-dilator fibres of the hindlimb, and on the nature of these fibres. J. Physiol. 26:1901;173.
3. Bevan S., Szolcsanyi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications (review). Trends Pharmacol. Sci. 11(8):1990;330-333.
4. Bevan S., Hothi S., Hughes G., James I.F., Rang H.P.et al. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol. 107(2):1992;544-552.
5. Brain S.D., Williams T.J. Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br. J. Pharmacol. 97(1):1989;77-82.
6. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., Macintyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 313(5997):1985;54-56.
7. Brain S.D., Tippins J.R., Morris H.R., Macintyre I., Williams T.J. Potent vasodilator activity of calcitonin gene-related peptide in human skin. J. Invest. Dermatol. 87(4):1986;533-536.
8. Buckley, T.L., Brain, S.D., Collins, P.D. and Williams, T.J., Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide, J. Immunol., 146 (10) (1991a) 3424-3430.
9. Buckley, T.L., Brain, S.D., Rampart, M. and Williams, T.J., Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation, Br. J. Pharmacol., 103 (2) (1991b) 1515-1519.
10. Buckley T.L., Brain S.D., Jose P.J., Williams T.J. The partial inhibition of inflammatory responses induced by capsaicin using the Fab fragment of a selective calcitonin gene-related peptide antiserum in rabbit skin. Neuroscience. 48(4):1992;963-968.
11. Donnerer J., Schuligoi R., Amann R. Time-course of capsaicin-evoked release of calcitonin gene-related peptide from rat spinal cord in vitro. Effect of concentration and modulation by Ruthenium Red. Regul. Pept. 37(1):1992;27-37.
12. Franco-Cereceda A., Lundberg J.M. Capsazepine inhibits low pH- and lactic acid-evoked release of calcitonin gene-related peptide from sensory nerves in guinea-pig heart. Eur. J. Pharmacol. 221(1):1992;183-184.
13. Gamse R., Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur. J. Pharmacol. 114(1):1985;61-66.
14. Geppetti P., Maggi C.A., Perretti F., Frilli S., Manzini S. Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart. Br. J. Pharmacol. 94(2):1988;288-290.
15. Hammond D.L., Ruda M.A. Developmental alterations in thermal nociceptive threshold and the distribution of immunoreactive calcitonin gene-related peptide and substance P after neonatal administration of capsaicin in the rat. Neurosci. Lett. 97(1-2):1989;57-62.
16. Handwerker H.O., Anton F., Kocher L., Reeh P.W. Nociceptor functions in intact skin and in neurogenic or non-neurogenic inflammation. Acta Physiol. Hung. 69(3-4):1987;333-342.
17. Handwerker H.O., Kilo S., Reeh P.W. Unresponsive afferent nerve fibres in the sural nerve of the rat. J. Physiol. 435:1991;229-242.
18. Holzer P., Jocic M. Cutaneous vasodilatation induced by nitric oxide-evoked stimulation of afferent nerves in the rat. Br. J. Pharmacol. 112(4):1994;1181-1187.
19. Holzer P., Wachter C., Heinemann A., Jocic M., Lippe I.T., Herbert M.K. Diverse interactions of calcitonin gene related peptide and nitric oxide in the gastric and cutaneous microcirculation (review). Can. J. Physiol. Pharmacol. 73(7):1995;991-994.
20. Hughes S.R., Brain S.D. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br. J. Pharmacol. 104(3):1991;738-742.
21. Hughes S.R., Brain S.D. Nitric oxide-dependent release of vasodilator quantities of calcitonin gene-related peptide from capsaicin-sensitive nerves in rabbit skin. Br. J. Pharmacol. 111(2):1994;425-430.
22. Jancso N. Role of the nerve terminals in the mechanism of inflammatory reactions. Bull. Millard Fillmore Hospital. 7:1960;53.
23. Jancso N., Jancso-Gabor A., Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. 31(1):1967;138-151.
24. Jancso N., Jancso-Gabor A., Szolcsanyi J. The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br. J. Pharmacol. 33(1):1968;32-41.
25. Karanth S.S., Springall D.R., Kuhn D.M., Levene M.M., Polak J.M. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene product 9.5 in man and commonly employed laboratory animals. Am. J. Anat. 191(4):1991;369-383.
26. Katayama M., Nadel J.A., Bunnett N.W., Di Maria G.U., Haxhiu M., Borson D.B. Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides. 12(3):1991;563-567.
27. Kessler F., Schmidt K.L., Rusch D. Thermometry in experimental inflammation. I. Studies on the circadian rhythm of the paw temperature in healthy rats and temperature behavior in acute inflammation after injection of kaolin, carrageenin and dextran (in German). Z. Rheumatol. 42(6):1983;337-342.
28. Kilo S., Schmeiz M., Koltzenburg M., Handwerker H.O. Different patterns of hyperalgesia induced by experimental inflammation in human skin. Brain. 117(Pt 2):1994;385-396.
29. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.F. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J. Neurophysiol. 66(1):1991;190-211.
30. LaMotte R.H., Lundberg L.E., Torebjork H.E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J. Physiol. 448:1992;749-764.
31. Lou Y.P. Regulation of neuropeptide release from pulmonary capsaicin-sensitive afferents in relation to bronchoconstriction. Acta Physiol Scand. 612(Suppl.):1993;1-88.
32. Lynn B., Faulstroh K., Pierau F.K. The classification and properties of nociceptive afferent units from the skin of the anaesthetized pig. Eur. J. Neurosci. 7(3):1995;431-437.
33. Maggi C.A., Astolfi M., Donnerer J., Amann R. Which mechanisms account for the sensory neuron blocking action of capsaicin on primary afferents in the rat urinary bladder? Neurosci. Lett. 110(3):1990;267-272.
34. Martling C.R., Saria A., Fischer J.A., Hokfelt T., Lundberg J.M. Calcitonin gene-related peptide and the lung: neuronal coexistence with substance P, release by capsaicin and vasodilatory effect. Regul. Pept. 20(2):1988;125-139.
35. Moskowitz, M.A., Lee, W.S. and Cutrer, F.M., Sensory neuropeptides in migraine. In: P. Geppetti and P. Holzer (Eds.), Neurogenic Inflammation, CRC Press, Boca Raton, FL, 1996, pp. 187-199.
36. Porszasz J., Jancso N. Studies on the action potentials of sensory nerves in animals desensitized with capsaicin. Acta Physiol. Acad. Sci. Hung. 16:1959;299-306.
37. Reeh P.W. Sensory receptors in mammalian skin in an in vitro preparation. Neurosci. Lett. 66(2):1986;141-146.
38. Sauer, S.K., Schäfer, D., Kress, M. and Reeh, P.W., Stimulated prostaglandin E2 release from rat skin, in vitro, Nauny-Schmiedeberg's Arch. Pharmacol., (1997) in press.
39. Seno N., Dray A. Capsaicin-induced activation of fine afferent fibres from rat skin in vitro. Neuroscience. 55(2):1993;563-569.
40. Simone D.A., Baumann T.K., LaMotte R.H. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain. 38(1):1989;99-107.
41. Szolcsanyi J. Antidromic vasodilatation and neurogenic inflammation. Agents Actions. 23(1-2):1988;4-11.
42. Urban L., Dray A. Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro. Neurosci. Lett. 134(1):1991;9-11.
43. Welk E., Fleischer E., Petsche U., Handwerker H.O. Afferent C-fibres in rats after neonatal capsaicin treatment. Pflugers Arch. Eur. J. Physiol. 400(1):1984;66-71.
44. Yeomans D.C., Proudfit H.K. Characterization of the foot withdrawal response to noxious radiant heat in the rat. Pain. 59(1):1994;85-94.